Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870). (Q36920423)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2007
edit
Language Label Description Also known as
English
Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870).
scientific article published on January 2007

    Statements

    11 references
    21 March 2019
    25 June 2019
    6 August 2019
    1 October 2019
    7 November 2019
    16 November 2019
    20 November 2019
    27 November 2019
    13 December 2019
    23 November 2020
    30 June 2021
    Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870). (English)
    9 references
    21 March 2019
    25 June 2019
    6 August 2019
    1 October 2019
    7 November 2019
    16 November 2019
    20 November 2019
    27 November 2019
    13 December 2019
    1 reference
    1 October 2019
    1 reference
    7 November 2019
    1 reference
    16 November 2019
    1 reference
    20 November 2019
    1 reference
    27 November 2019
    1 reference
    13 December 2019
    1 reference
    23 November 2020
    1 reference
    30 June 2021

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit